Influence of physicians' risk perception on switching treatments between high- efficacy and non-high-efficacy disease-modifying therapies in multiple sclerosis

Seifer, G; Arun, T; Capela, C; Laureys, G; Jones, E; Dominguez-Castro, P; de la Rosa, RS; Hiltl, S; Iaffaldano, P

Seifer, G (通讯作者)，Novartis Pharm AG, Med Affairs, WSJ-202 2 02, CH-4056 Basel, Switzerland.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023; 76 ():

Abstract

Background: The decision of initiating treatment for multiple sclerosis (MS) with a high-efficacy DMT (HE DMT) or non-high-efficacy DMT (non-HE DMT) i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索